Here is what the page “Medicare AI Prior Authorization Pilot Criticized for Rushed Rollout and Patient Care Delay” contains. Newly released documents reveal that Medicare’s ambitious artificial intelligence pilot aimed at streamlining prior authorization processes was launched too quickly, resulting in significant delays in patient care. The program, overseen by the Centers for Medicare & Medicaid Services (CMS), sought to use AI tools from companies like IBM Watson Health and Cerner to automate approval decisions for medical treatments. However, internal reviews show that the system’s early deployment lacked sufficient testing, leading to inaccurate recommendations and bottlenecks that delayed critical care for beneficiaries—particularly in rural and underserved areas.
Key stakeholders, including CMS officials and healthcare providers, have expressed concern over the lack of transparency and oversight during the rollout. The pilot, initially announced in late 2023 and implemented across select regions by early 2024, was intended to reduce administrative burdens on providers and improve access to timely treatment. The full version stays on the original page, which this listing opens directly.